Prelude Therapeutics Inc
NASDAQ:PRLD

Watchlist Manager
Prelude Therapeutics Inc Logo
Prelude Therapeutics Inc
NASDAQ:PRLD
Watchlist
Price: 0.8147 USD -8.16% Market Closed
Market Cap: 46m USD

Wall Street
Price Targets

PRLD Price Targets Summary
Prelude Therapeutics Inc

Wall Street analysts forecast PRLD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PRLD is 3.825 USD with a low forecast of 1.01 USD and a high forecast of 5.25 USD.

Lowest
Price Target
1.01 USD
24% Upside
Average
Price Target
3.825 USD
369% Upside
Highest
Price Target
5.25 USD
544% Upside
Prelude Therapeutics Inc Competitors:
Price Targets
206650
EuBiologics Co Ltd
23% Upside
NXTC
NextCure Inc
675% Upside
GRAL
Grail Inc
21% Downside
LEGN
Legend Biotech Corp
103% Upside
ONCO
Oncopeptides AB
59% Upside
TGTX
TG Therapeutics Inc
17% Upside
KRYS
Krystal Biotech Inc
41% Upside
QURE
Uniqure NV
157% Upside

Revenue
Forecast

Revenue Estimate
Prelude Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Prelude Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
Prelude Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-19%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PRLD's stock price target?
Price Target
3.825 USD

According to Wall Street analysts, the average 1-year price target for PRLD is 3.825 USD with a low forecast of 1.01 USD and a high forecast of 5.25 USD.

Back to Top